文献速递认知障碍与痴呆

PPP4R3A基因变异可防止阿尔茨海默病相关代谢下降

A variant in PPP4R3A protects against alzheimer-related metabolic decline.
PubMed 文献 · Ann Neurol · 2017-12-04

研究以阿尔茨海默病神经影像计划中606名参与者的后扣带回皮层FDG PET代谢下降为表型进行全基因组关联分析,发现PPP4R3A基因rs2273647-T与代谢下降减缓全基因组显著相关(p=4.44×10-8)。在870名独立样本中该变异与MCI或AD转化风险降低(p=0.038)及痴呆患者认知下降减缓(p=3.41×10-15)相关。

要点

  • rs2273647-T与后扣带回FDG代谢下降减缓全基因组显著相关。
  • 该变异与MCI或AD转化风险降低及痴呆患者认知下降减缓相关。
  • PPP4R3A可能是神经退行性疾病和AD治疗的潜在靶点。

核心结论

  • PPP4R3A是与AD风险和进展相关的基因,其变异rs2273647-T具有保护作用。

研究设计与样本

  • 对阿尔茨海默病神经影像计划参与者(n=606)后扣带回FDG PET代谢下降进行全基因组关联分析。
  • 在独立数据集(n=870)中评估显著SNP对疾病风险和纵向认知表现的影响。
  • 使用两个RNA测序数据集(n=210和n=159)评估SNP对基因表达的影响。

主要发现

  • rs2273647-T与后扣带回FDG代谢下降减缓全基因组显著相关(p=4.44×10-8)。
  • 在独立数据集中,该变异与MCI或AD转化风险降低相关(p=0.038)。
  • 在发生痴呆的个体中,该变异与认知下降减缓相关(p=3.41×10-15)。
  • 该变异与外周血基因表达改变及颞叶皮层PPP4R3A转录表达改变相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: A reduction in glucose metabolism in the posterior cingulate cortex (PCC) predicts conversion to Alzheimer's disease (AD) and tracks disease progression, signifying its importance in AD. We aimed to use decline in PCC glucose metabolism as a proxy for the development and progression of AD to discover common genetic variants associated with disease vulnerability. METHODS: We performed a genome-wide association study (GWAS) of decline in PCC fludeoxyglucose F 18 ([18 F] FDG) positron emission tomography measured in Alzheimer's Disease Neuroimaging Initiative participants (n = 606). We then performed follow-up analyses to assess the impact of significant single-nucleotide polymorphisms (SNPs) on disease risk and longitudinal cognitive performance in a large independent data set (n = 870). Last, we assessed whether significant SNP influence gene expression using two RNA sequencing data sets (n = 210 and n = 159). RESULTS: We demonstrate a novel genome-wide significant association between rs2273647-T in the gene, PPP4R3A, and reduced [18 F] FDG decline (p = 4.44 × 10-8 ). In a follow-up analysis using an independent data set, we demonstrate a protective effect of this variant against risk of conversion to MCI or AD (p = 0.038) and against cognitive decline in individuals who develop dementia (p = 3.41 × 10-15 ). Furthermore, this variant is associated with altered gene expression in peripheral blood and altered PPPP4R3A transcript expression in temporal cortex, suggesting a role at the molecular level. INTERPRETATIONS: PPP4R3A is a gene involved in AD risk and progression. Given the protective effect of this variant, PPP4R3A should be further investigated as a gene of interest in neurodegenerative diseases and as a potential target for AD therapies. Ann Neurol 2017;82:900-911.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Christopher L, Napolioni V, Khan RR, et al. A variant in PPP4R3A protects against alzheimer-related metabolic decline. Ann Neurol. 2017. PMID: 29130521. doi:10.1002/ana.25094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。